Larvol Delta - The-VEXASMDS-Interface-Integrating-Morphological-Markers-and-Clonal-Evolution-to-Predict-Response-to-Targeted-Myeloid-Cell-Therapies

Jakafi (ruxolitinib) - Incyte

https://www.sciencedirect.com/science/article/abs/pii/S2152265026022263

Teshika Yalla MBBS

Sep 1, 2026

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next